Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Small Cell Lung Cancer (SCLC)

Small Cell Lung Cancer (SCLC) Newsletter

Samuraciclib by Carrick Therapeutics for Small-Cell Lung Cancer: Likelihood of Approval 30 Dec 2024 21:08 GMT
… , ovarian cancer, prostate cancer, and small-cell lung cancer. It is administered through the …
Ponatinib hydrochloride by Takeda Pharmaceutical for Non-Small Cell Lung Cancer: Likelihood of Approval 30 Dec 2024 18:27 GMT
… leukemia (ALL), advanced biliary cancer, lung cancer, second-line patients with chronic … myeloma, mantle cell lymphoma, non-small cell lung cancer and chronic myeloid leukemia. While …
European Commission Approves RYBREVANT®▼ (Amivantamab) In Combination With LAZCLUZE®▼ (Lazertinib) For The First-Line Treatment Of Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer 30 Dec 2024 09:10 GMT
… of all lung cancer cases.3 Lung cancer is Europe… Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer … brain metastases in non-small cell lung cancer (NSCLC) patients – … EGFR Inhibitor-Resistant Lung Tumors. Cancer Res. …
BGB-10188 by BeiGene for Non-Small Cell Lung Cancer: Likelihood of Approval 29 Dec 2024 18:47 GMT
… , advanced solid tumors including non-small cell lung cancer, small-cell lung cancer metastatic melanoma, head and neck …
IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for SHR-4849, a Novel Phase 1 DLL3 Topo-I-Payload ADC Targeting SCLC and NET Solid Tumors 29 Dec 2024 15:12 GMT
… DLL3 highly expressed in Small Cell Lung Cancer (SCLC) and Neuroendocrine Tumors ( … clinical signals in small-cell lung cancer with a … Among 11 evaluable small cell lung cancer (SCLC) subjects treated at … , including in SCLC and Neuroendocrine Tumors …
AstraZeneca Tagrisso approved in EU for patients with unresectable EGFR-mutated lung cancer 27 Dec 2024 09:45 GMT
… with locally advanced, unresectable non-small cell lung cancer (NSCLC) whose tumours have … unresectable, EGFR-mutated non-small cell lung cancer, delivering the first targeted … therapy in EGFR-mutated non-small cell lung cancer.” The safety and tolerability …
Verastem Oncology Announces FDA Acceptance and Priority Review of New Drug Application for Avutometinib in Combination with Defactinib for the Treatment of Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer 30 Dec 2024 21:37 GMT
… whose KRAS G12C mutant non-small cell lung cancer progressed on a G12C inhibitor …
The biggest medical advances of 2024 30 Dec 2024 21:23 GMT
… bomb. Tagrisso, used in non-small cell lung cancer that tests positive for a …
Disitamab vedotin by Pfizer for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer): Likelihood of Approval 30 Dec 2024 21:08 GMT
… breast cancer, HER2 expressing non-small cell lung cancer, non-muscle invasive bladder cancer …
Plasmodium Immunotherapy by CAS-Lamvac Biotech for Colorectal Cancer: Likelihood of Approval 30 Dec 2024 21:08 GMT
… for the treatment of non-small cell lung cancer, advanced breast cancer, advanced liver …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS